P&C market intelligence

DATASORA

WireIndependent research

Last refresh · —

Next refresh · 6:00 a.m. ET

Live intelligence on the market Sompo writes — product-line overviews, placement, and the industry calendar. Product lines, placement by broker, and whitespace sit beside the Sompo, brokers, M&A, private equity, and construction desks. News coverage is industry-wide.

Next · PLUS International Conference · Nov 8–11, 2026 · 5d

Industry verticals · industry tape

Life sciences

Clinical trial, products, and manufacturing liability for pharma, devices, and biologics. Capacity exists but terms still hinge on trial phase, territory, and recall.

Sompo writes this. Sompo writes life-sciences programs for development, manufacturing, and distribution of drugs, devices, supplements, and biologics. Headlines below are the complete industry, not Sompo-only.

  • Clinical trial coverage territory
  • Product / recall attachment
  • CDMO and device-manufacturing casualty

Analyst brief · Life sciences

mixed50

No recent coverage for Life sciences. Clinical trial, products, and manufacturing liability for pharma, devices, and biologics. Capacity exists but terms still hinge on trial phase, territory, and recall.

Storylines

  • Clinical trial, products, and manufacturing liability for pharma, devices, and biologics. Capacity exists but terms still hinge on trial phase, territory, and recall.

Risks

  • No notable risks flagged for Life sciences.

Watch

  • Clinical trial coverage territory
  • Product / recall attachment
  • CDMO and device-manufacturing casualty

Split market on Life sciences. Softening lines are colliding with the classes that still hurt.

Industry wire

On Life sciences

0

No stories on this beat yet. Try another search.